Catalonia brings together a robust and growing network of institutions dedicated to research, development and manufacturing of advanced therapy medicinal products (ATMPs). This section showcases the region’s capabilities across the full value. With internationally recognized research centers, leading hospitals and cutting edge biomanufacturing infrastructure, Catalonia offers the scientific excellence, talent and technological capabilities needed to accelerate cell and gene therapy innovation. Explore the organizations driving progress in this strategic field.
Catalonia’s capabilities
in cell and gene therapies
Catalonia’s scientific strength
Strategic partners for cell and gene therapy innovation
CAR-T development in oncology
CAR-T development in oncology
Combining translational research, clinical trials and GMP manufacturing to accelerate personalized immunotherapies for cancer patients with high medical need.
Read more
Gene therapy development
Gene therapy development
Advancing gene editing, vector design and preclinical validation to develop innovative therapies targeting genetic disorders and complex, high burden diseases.
CAR-T in inflammatory diseases
CAR-T in inflammatory diseases
Exploring CAR-T applications beyond oncology to modulate immune responses in autoimmune and inflammatory diseases through clinical research and early development.
CAR-NK
CAR-NK
Developing CAR-NK therapies as a next generation immunotherapy platform, combining antitumor efficacy with improved safety and off-the-shelf potential.
Autologous CAR-T
Autologous CAR-T
Advancing autologous CAR-T therapies with hospital based manufacturing, personalized design and clinical implementation for hematological cancers and rare oncological indications.
TIL
TIL
Developing TIL therapies to harness patients’ own immune cells for solid tumor treatment, combining cell expansion, GMP production and clinical translation.